Related by context. All words. (Click for frequent words.) 68 metaplasia 67 extramedullary 67 NMIBC 67 bronchoalveolar lavage 67 TIMP 1 66 hypermethylated 66 Immunohistochemical staining 66 prostate carcinoma 66 metastatic malignant 65 RRM1 65 papillary renal cell carcinoma 65 colorectal carcinoma 65 nonmetastatic 65 mutated K ras 65 tumor histology 65 histological subtype 65 biochemical relapse 65 NSCLC tumors 65 underwent resection 65 SSc 65 thyroid carcinoma 65 thyroglobulin 65 chromosomal mutations 65 pancreatic adenocarcinoma 65 transarterial 64 leukocyte counts 64 thrombocytopenic 64 lesional 64 BRAF V#E mutation 64 esophageal carcinoma 64 genotypic resistance 64 nutlin 3a 64 transabdominal 64 liver metastasis 64 Hypertrophy 64 multivariable analysis 64 paraganglioma 64 thalidomide Thalomid 64 Doppler echocardiography 64 pulmonary metastasis 64 haematologic 64 recurrent glioblastoma multiforme 64 ABL1 64 electrophysiologic 64 nodal metastasis 64 surgically resected 64 glomerular 64 gadolinium enhanced 64 monoclonal gammopathy 64 MR spectroscopy 64 echocardiographic parameters 64 superior mesenteric artery 64 LHRH receptor positive 64 transcranial Doppler ultrasound 64 HLA DQ2 64 cisplatin resistant 64 HLA DRB1 63 Histological 63 unresectable tumors 63 TOP2A 63 FDG uptake 63 colorectal adenoma 63 HER2 overexpression 63 insertional 63 clinicopathologic 63 histopathologic examination 63 Histologic 63 breast carcinomas 63 lymph node metastasis 63 lactate dehydrogenase 63 pT2 63 hepatoma 63 T1c 63 primary hyperparathyroidism 63 urothelial carcinoma 63 neuritic 63 microsatellite instability 63 metastatic lymph nodes 63 GSTP1 63 hormone receptor status 63 pretransplant 63 prostate cancer CaP 63 posttransplant 63 immunostaining 63 aminotransferase 63 lactate dehydrogenase LDH 63 Subgroup analysis 63 metabolomic profiles 63 clinicopathological 63 histologic subtype 63 ADAMTS# 63 IDH1 mutation 63 SNP rs# [001] 63 hMG 63 annexin 63 thymoma 63 bronchoalveolar lavage fluid 63 edifoligide 63 Immunohistochemical analysis 63 HER2 expression 63 bladder carcinoma 62 gastrointestinal stromal tumors GISTs 62 Hurthle cell 62 ALB # 62 echo planar 62 appendiceal 62 tumorigenicity 62 biopsy specimen 62 relapsed MM 62 Figure 2C 62 extracapsular extension 62 Fine needle aspiration 62 Papillary 62 urothelial 62 glutamic acid decarboxylase 62 gastric carcinoma 62 stratifying patients 62 Cyclin E 62 cTnI 62 immunoreactivity 62 immunohistochemical staining 62 mucinous 62 acute aortic dissection 62 cerebral vasospasm 62 Mutational 62 submandibular gland 62 cardiac perfusion 62 cellularity 62 TIMP 62 B7 H3 62 renal cell carcinomas 62 pT3 62 underwent surgical resection 62 KRAS oncogene 62 cytokeratin 62 gefitinib Iressa 62 hepatocellular carcinomas 62 epithelial tumors 62 isoenzyme 62 mediated inhibition 62 CD# expression [001] 62 F FDG PET 62 ERalpha 62 chemoradiation therapy 62 arteriography 62 affective psychosis 62 inverse agonist 62 tumor necrosis 62 radiochemotherapy 62 invasive lobular 62 pathologic diagnosis 62 spontaneous regression 62 biliary tract cancer 62 BRCA1 BRCA2 62 SCN5A 62 DAS# CRP 62 EGFR TKI 62 myocyte 62 fibroma 62 COL#A# 61 flow cytometric analysis 61 PSA nadir 61 elevated transaminases 61 graft occlusion 61 distant metastasis 61 allogeneic HSCT 61 hamartomas 61 mutated KRAS 61 tumoral 61 myogenic 61 multivariate Cox 61 striated muscle 61 morphometric vertebral fractures 61 AST ALT 61 antiretroviral naïve 61 operable breast cancer 61 oligomerization 61 Clusterin 61 PDGF B 61 transesophageal echocardiography 61 HSCT 61 T2 lesions 61 angiographically 61 Scintigraphy 61 IL#B 61 gastric adenocarcinoma 61 bronchoalveolar lavage BAL 61 peritoneal carcinomatosis 61 Aurora Kinase 61 LRP5 61 cell adhesion molecule 61 clinicopathological features 61 carcinoids 61 SNP rs# [002] 61 TET2 61 osteoid 61 renal cysts 61 CEACAM1 61 diffusion tensor 61 siRNA knockdown 61 proton MR spectroscopy 61 bronchoalveolar 61 schwannomas 61 pCR 61 colorectal adenocarcinoma 61 circadian genes 61 Human Leukocyte Antigen 61 multivariate analyzes 61 ERBB2 61 pulmonary metastases 61 recovery CRp 61 QRS interval 61 localized renal 61 Leydig cell 61 hepatic fibrosis 61 murine model 61 breast cancer subtypes 61 monocytic 61 GSTT1 61 QTcF 61 neoplasias 61 interstitial fibrosis 61 debulking surgery 61 resected pancreatic cancer 61 NAT2 61 paricalcitol 61 hepatic arterial 61 gp# protein [002] 61 HepG2 cells 61 CC genotype 61 LV dysfunction 61 tumor regressions 61 gene amplification 61 ERK signaling 61 transcranial Doppler 61 pituitary adenomas 61 myxoma 61 CDK inhibitor 61 neoplastic cells 61 HIV HCV coinfected 61 abacavir Ziagen 61 hamartoma 61 adrenalectomy 61 electroencephalographic 61 FDG PET scans 61 ABCB1 61 RYGB surgery 61 cardiac myocyte 61 atrioventricular block 61 serine protease 61 neurofibromas 61 Aspergillus nidulans 61 cytogenetic abnormalities 61 logistic regression analysis 61 lymphocyte count 61 NF kB pathway 61 Fibroblast 61 proto oncogene 61 node metastases 61 umbilical artery 61 neurosensory 61 constitutively expressed 61 genomewide 61 osteolytic 61 APOE genotype 61 telomerase inhibition 61 prostate cancer PCa 60 histopathological 60 TUNEL 60 mitoxantrone chemotherapy 60 troponins 60 PDGFR 60 antral 60 posttranslational modification 60 leiomyoma 60 Cathepsin B 60 vastus lateralis 60 replicase 60 acyltransferase 60 rifamycins 60 pretreatment serum 60 interobserver 60 #S rRNA gene 60 Microarray analysis 60 receptor tyrosine kinase inhibitor 60 MMP# 60 hyperalgesia 60 eosinophil count 60 clinico pathological 60 PDGF BB 60 metastatic gastric 60 Preoperatively 60 micrometastasis 60 locoregional recurrence 60 scintigraphic 60 Univariate analysis 60 lung metastasis 60 LRAT 60 imexon 60 nondiabetic patients 60 FUS1 60 dorsal root ganglion 60 mononuclear 60 IFN alpha 2a 60 osteoclastic 60 Prognostic significance 60 CYT# potent vascular disrupting 60 neuro endocrine 60 seminal vesicle invasion 60 beta1 integrin 60 pancreatic ductal 60 MLH1 60 RT PCR assay 60 #Gy 60 Histone deacetylase 60 Ultrasonographic 60 intact parathyroid hormone 60 completely resected 60 sinonasal 60 adducts 60 serum cortisol 60 isotype 60 Stage IIIb 60 HBeAg 60 MALT lymphoma 60 alkylating 60 von Hippel Lindau 60 total thyroidectomy 60 Allogeneic 60 cisplatin gemcitabine 60 coronary stenosis 60 ductal adenocarcinoma 60 metalloproteinase 60 metabolizing enzyme 60 CR nPR 60 GLUT4 60 -#.# log# 60 aMCI precursor 60 PI3K AKT 60 wildtype 60 acinar 60 histologically proven 60 EGF receptors 60 systolic dysfunction 60 Preoperative 60 invasive carcinomas 60 femoral neck fracture 60 essential thrombocythemia 60 perfusion defects 60 concurrent chemoradiation 60 atypical hyperplasia 60 #p# [003] 60 somatostatin analog 60 supratentorial 60 colony stimulating factor 60 Angiotensin converting enzyme 60 mTOR inhibitors 60 intravenous cyclophosphamide 60 syngeneic 60 carcinoembryonic antigen 60 Parathyroid hormone 60 Patency 60 denervation 60 smoldering myeloma 60 Inhaled nitric oxide 60 autonomic dysfunction 60 metastatic neuroendocrine tumors 60 electrocardiographic 60 miRNA expression 60 proband 60 hyperplastic 60 colon carcinoma 60 idiopathic PAH 60 hematological parameters 60 comparator arm 60 intima media thickness 60 histologically 60 MYBPC3 60 cytogenic 60 intracerebral 60 ANCA associated 60 FDG PET imaging 60 hA# 60 PEG IFN 60 prognostic significance 60 Histopathologic examination 60 aggrecan 60 MGUS 60 intracoronary 60 mitochondrial respiration 60 hemodynamically significant 60 Tasigna prolongs 60 mitogen activated protein kinases 60 fatty infiltration 60 constipation predominant IBS 60 choroidal neovascularization 60 autologous hematopoietic stem cell 60 urate oxidase 60 EGFR receptor 60 logistic regression model 60 Haptoglobin 60 allogeneic hematopoietic stem cell 60 osteochondroma 60 anaplastic lymphoma kinase ALK 60 hypervascular 60 intraventricular 60 gastric carcinomas 60 plexiform 60 lymphangiogenesis 60 seminomas 60 alanine aminotransferase ALT 60 Multiple Myeloma MM 60 hematopoietic cancers 60 dyssynchrony 60 baseline LDH 60 DNA methylation patterns 60 Soft Tissue Sarcoma 60 arthrography 60 ptau 60 Neurogenic 60 proteomic analysis 60 postoperative complication 60 human leukocyte antigen HLA 60 Electroencephalography 60 Synovial 60 ERK1 2 60 Amino acid 60 lung carcinomas 60 vascular anatomy 60 busulfan 60 PCA3 gene 60 paraneoplastic 60 P selectin 60 aromatase inhibitor therapy 60 Her2/neu 60 β blockers 60 ascending aortic 60 homozygote 60 transient elastography 60 prognostic biomarker 60 transvaginal sonography 60 normal karyotype 60 Estrogen Receptor 60 lymphatic vessel 60 IPAH 60 Insulin sensitivity 60 hyperacute 60 beta globin 60 hypoperfusion 60 florbetaben 59 myelofibrosis polycythemia vera 59 pro angiogenic 59 tumor xenograft models 59 hypothalamic pituitary 59 SYN# 59 aspartate aminotransferase 59 antithymocyte globulin 59 antiphospholipid antibodies 59 SELDI TOF MS 59 FDG-PET/CT 59 periocular 59 serum HBV DNA 59 M1 muscarinic 59 SUVmax 59 budding yeast 59 postintervention 59 endometrioid 59 pancreatic carcinoma 59 apolipoprotein E4 59 diagnostic biomarker 59 ovarian carcinoma 59 esophageal gastric 59 bacterial prostatitis 59 transgenic mouse models 59 chemosensitivity 59 neoplastic lesions 59 FGFR3 59 Intracoronary 59 chemoradiotherapy 59 Naive Patients 59 prognostic indicators 59 radical prostatectomy RP 59 urethral stricture 59 chronic eosinophilic leukemia 59 osteosarcomas 59 intraepithelial neoplasia 59 sonographically guided 59 demonstrated antitumor activity 59 sitosterol 59 T1 weighted images 59 AMACR 59 Duodenal 59 intensity modulated 59 rFSH 59 semiquantitative 59 malignant ascites 59 HRCT 59 antibody titer 59 BRAF V#E 59 pediatric acute lymphoblastic 59 Figure 1C 59 Lymph node 59 quasispecies 59 retroperitoneal 59 Histologically 59 oral squamous cell 59 prostate cancer metastases 59 adipogenic 59 TEL AML1 59 anterior temporal 59 K ras mutations 59 papillary carcinoma 59 ADPKD 59 amyloid plaque formation 59 deep venous thromboses 59 methylation patterns 59 leukocyte count 59 NR#A# 59 complement inhibitor eculizumab 59 lymphoid tumors 59 inducible nitric oxide synthase 59 diabetic kidney 59 CMV infections 59 glycosylated hemoglobin HbA1c 59 autologous SCT 59 RT qPCR 59 somatic mutations 59 proteoglycan 59 myelodysplastic myeloproliferative diseases 59 CD#c 59 stage IIIb IV 59 neurologic progression 59 ALK gene 59 sarcomatoid 59 Kinoid 59 osteopenic 59 atrioventricular 59 chromosome #q#.# [001] 59 GBA mutations 59 promoter hypermethylation 59 seropositivity 59 atheroma volume 59 metabolite concentrations 59 ABCB1 gene 59 heterozygotes 59 NMES 59 protein tyrosine phosphatase 1B 59 transthoracic 59 orthotopic liver transplantation 59 gastric cardia 59 ischemic mitral regurgitation 59 Familial Hypercholesterolemia 59 vaso occlusive crisis 59 Dilated Cardiomyopathy 59 nadolol 59 artery stenosis 59 left ventricular diastolic 59 isoprostane 59 endometrial adenocarcinoma 59 stent stenosis 59 QTc prolongation 59 osteoprotegerin 59 succinate dehydrogenase 59 complete cytogenetic response 59 euthymic patients 59 Multivariate analysis 59 humanised monoclonal antibody 59 C#Y 59 breast carcinoma 59 Upregulation 59 PTEN gene 59 T1a 59 immunohistochemical 59 obstructive coronary artery 59 neoadjuvant treatment 59 surgically resectable 59 VATS lobectomy 59 lymphocytic 59 protein tyrosine phosphatase 59 posttreatment 59 FLT3 ITD 59 laterality 59 breast cancer metastasis 59 hepatorenal syndrome 59 quantitative EEG 59 gene polymorphisms 59 ultrastructure 59 #F FDG PET 59 inhibin B 59 interferon ribavirin 59 interstitial brachytherapy 59 mda 7 59 antigen binding 59 gemcitabine Gemzar 59 transaminase 59 plasmid encoding 59 metastatic bladder 59 tissue transglutaminase 59 cervicovaginal 59 JAK2 V#F 59 hypophosphatemia 59 PTPN# 59 suppresses tumor 59 c KIT 59 thymectomy 59 proteomic analyzes 59 preoperative diagnosis 59 repolarization 59 hyperintensity 59 carboxyl terminal 59 gemcitabine cisplatin 59 H#K#me# 59 autoregulation 59 lung nodule 59 intestinal metaplasia 59 adnexal mass 59 alkaline phosphatase ALP 59 Cystatin C 59 phenotypic expression 59 APOL1 59 malignant prostate 59 potent inducer 59 alefacept 59 benign neoplasms 59 preoperative PSA 59 Circulating tumor cells 59 methyltransferase 59 Legg Calvé Perthes disease 59 CIN2 + 59 pancreatic endocrine 59 potentiation 59 Univariate 59 gallium nitrate 59 5 HT2A serotonin 59 immunohistochemical analysis 59 gemcitabine carboplatin 59 scleral buckling 59 eosinophilia 59 AGTR1 59 fibrosarcoma 59 hypereosinophilic syndrome 59 axillary lymph nodes 59 Hematopoietic 59 specific antigen PSA 59 nonischemic 59 covalently bound 59 Surgical resection 59 hepatic lesions 59 tumors GIST 59 Alanine 59 paclitaxel cisplatin 59 urothelial bladder cancer 59 sustained ventricular tachycardia 59 hematopoietic progenitor cells 59 ankyrin repeat 59 transcriptional repressor 59 metabolizer 59 UVB induced 59 mammary duct 59 liver histology 59 PCR RFLP 59 resection arthroplasty 59 radioligand 59 nasopharyngeal carcinoma 59 Chronic pancreatitis 59 PTHrP 59 cervical lymph nodes 59 alpha folate receptor 59 irreversible inhibitor 59 troponin T 59 TNFalpha 59 Arrhythmogenic 59 supernatants 59 susceptibility loci 59 KRAS mutation 59 ritonavir boosted 59 nodal metastases 59 iPS derived 59 T2 weighted images 59 Trichophyton rubrum 59 hepatic enzyme 59 radiosensitivity 59 p# biomarker 59 autophagic 59 Safinamide 59 E3 ligase 59 kinase inhibition 59 Ala Ala 59 LVNC 59 explants 59 PITX2 59 splenic 59 metastatic malignant melanoma 59 p# antigen 58 Fas ligand 58 nicotinic acetylcholine receptor 58 dermal collagen 58 metastatic lesion 58 visceral metastases 58 stem cell pluripotency 58 TRAIL induced apoptosis 58 CREBBP 58 intraobserver 58 lumbar disk herniation 58 leucocytes 58 LV ejection fraction 58 metachronous 58 airway hyperresponsiveness 58 lymphocytosis 58 CSF biomarkers 58 extracranial 58 immunoblotting 58 rituximab Rituxan 58 postop 58 tumor infiltrating lymphocytes 58 anaplastic astrocytoma AA 58 mRNA expression 58 Histopathologic 58 cytoreduction 58 aortic root replacement 58 Interferon beta 58 adiponectin concentrations 58 liver resection 58 maternal serum 58 HNSCC 58 perineural invasion 58 5alpha reductase 58 MGd 58 xenograft tumors 58 pegylated liposomal doxorubicin 58 flow cytometric 58 NPHP 58 percutaneous biopsy 58 epiphysis 58 lymphocyte counts 58 RhuDex R 58 mitral annular 58 clefting 58 pelvic lymphadenectomy 58 Index CDAI 58 carcinoid 58 homodimer 58 estramustine 58 potent suppressor 58 IgA deficiency 58 targeted nucleotide prodrug 58 needle aspiration 58 creatine kinase MB 58 Lodamin 58 myopathies 58 gag pol 58 calculi 58 differentially expressed genes 58 uricase 58 histone modifications 58 antiangiogenic therapy 58 computed tomographic 58 progression TTP 58 impaired glucose metabolism 58 glutamyl 58 FUSILEV enhances 58 diabetes mellitus DM 58 prefrontal cortical 58 biochemical recurrence 58 Electrophysiological 58 deacetylation 58 androgen ablation 58 meningeal 58 kidney urologic 58 morphometric analysis 58 gene MECP2 58 CYP#A# enzyme 58 intraperitoneal injection 58 pamidronate 58 EGFR mutant 58 colorectal tumor 58 neural progenitor 58 antiapoptotic 58 pheochromocytomas 58 pathophysiological effects 58 osteoid osteoma 58 patientswith 58 Prognostic factors 58 radiographic findings 58 hematoxylin eosin original 58 PROSTVAC VF 58 C#BL/#J mice 58 ^ sup #m 58 peritoneal fluid 58 bone scintigraphy 58 microvessel 58 SCD1 58 differential gene expression 58 polyposis 58 intestinal permeability 58 cytologically confirmed 58 MAGE A3 ASCI 58 genetic locus 58 Annexin V 58 trastuzumab Herceptin ® 58 HLA DR4 58 epirubicin cyclophosphamide 58 genomic alterations 58 helical CT 58 serine threonine kinase 58 TRAIL R1 58 humoral responses 58 pylori 58 pharmacodynamic parameters 58 promoter methylation 58 peroxisomal 58 NRTI resistance 58 CD# expression [002] 58 transfusion syndrome 58 premalignant lesions 58 missense mutations 58 ligand receptor 58 intravesical infusion therapy 58 computed tomographic scan 58 Androgen receptor 58 Neuropsychiatric Inventory NPI 58 epoetin alpha 58 #p# [001] 58 HCV replication 58 Cytotoxic T 58 hyperintense lesions 58 ligand induced 58 subarachnoid hemorrhage SAH 58 NS3 protease 58 susceptibility locus 58 TRAIL R2 58 cranial irradiation 58 thrombocytosis 58 histologic findings 58 myocardial necrosis 58 aneurysmal 58 microglial activation 58 bronchogenic carcinoma 58 keratoplasty 58 microglial 58 CYP #D# 58 Eg5 58 Gastrointestinal Stromal Tumors 58 paternally inherited 58 HLA DR2 58 liver transplant recipients 58 aspartate aminotransferase AST 58 chemokine receptor 58 basal bolus regimen 58 bronchial epithelial cells 58 P ≤ 58 corneal epithelial 58 resistant hormone refractory 58 Western blotting 58 HBeAg negative 58 familial clustering 58 colocalization 58 PSADT 58 transthyretin 58 CDKN2A 58 TOP2A gene 58 morphologic 58 Ab# 58 tracer uptake 58 undergoing hematopoietic stem 58 Ribavirin causes 58 Flu Cy 58 anthracycline induced 58 conditional logistic regression 58 #p#.# [002] 58 glaucomatous 58 receptor inhibitor 58 potent antiproliferative 58 Degarelix 58 gene polymorphism 58 follicular Non Hodgkin 58 C#BL 6 mice 58 T1 weighted 58 achieved statistical significance 58 glycolipid 58 transcriptome sequencing 58 caspofungin 58 galiximab 58 dexpramipexole 58 isolated perfused 58 allele frequencies 58 cardiac repolarization 58 mild renal insufficiency 58 radioiodine therapy 58 bullous 58 lymphocytic leukemia 58 bi phasic 58 leukemia AML 58 alpha fetoprotein AFP 58 epithelial ovarian 58 Adenomas 58 tumor subtype 58 invasive ductal 58 subclinical disease 58 transcriptomic 58 Leukemias 58 Endothelial 58 NPM1 mutation 58 Fig. 1D 58 p# activation 58 flavopiridol 58 overt nephropathy 58 stereotactic radiotherapy 58 hip resurfacing arthroplasty 58 granulocyte 58 SGPT 58 osteoblast 58 VEGF induced 58 Endometrial 58 metastatic pancreatic 58 Tyrosine Kinase Inhibitor 58 subcellular localization 58 pretargeting 58 distal radial fractures 58 carotid IMT 58 prostate adenocarcinoma 58 neuromuscular junctions 58 cutis 58 GPI anchored 58 rs# [004] 58 computed tomographic scans 58 cardiomyocyte 58 biochemical markers 58 TGF ß1 58 Propionibacterium 58 multivariable analyzes 58 adjuvant cisplatin 58 radiolabeled TM# 58 clinically detectable 58 HER2 amplified 58 Protein Kinase C 58 occlusive disease 58 plain radiographs 58 methylation markers 58 Folfox 58 liver biopsies 58 apo E 58 p = NS 58 transgene expression 58 null responder 58 Prefrontal 58 thyroid peroxidase 58 postoperative chemotherapy 58 Dysregulation 58 administered intraperitoneally 58 HER2 amplification 58 haematopoietic 58 laparoscopic nephrectomy 58 transcriptomics 58 monophasic 58 observational cohort study 58 Cardiotoxicity 58 allelic variants 58 dorsal root ganglia 58 endothelial keratoplasty 58 adjuvant systemic 58 Decitabine 58 germline mutations 58 variant rs# 58 cis retinoic acid 58 adrenoceptor 58 mRNA encoding 58 polycythemia vera essential thrombocythemia 58 stem cell engraftment 58 coronary artery atherosclerosis 58 demethylation 58 cholangiocarcinoma 58 mevalonate 58 carcinomatosis 58 response pCR 58 gene rearrangements 58 E selectin 58 fibrin deposition 58 c Src 58 experimentally induced 58 daily subcutaneous injections 58 nanomolar 58 multivariate logistic regression 58 branching morphogenesis 58 HER2 positivity 58 enteroviral 58 chimeric monoclonal antibody 58 thymic carcinoma 58 NMDAR 58 artery embolization 58 del 5q 58 serum markers 58 grade squamous intraepithelial 58 upregulating 58 cetuximab Erbitux R 58 downregulated 58 tryptase 58 dyskeratosis congenita 58 p# mitogen activated